INTRODUCTION
The thymus is the primary organ in which T cell development occurs. In the adult, circulating thymocyte progenitors, originating from the bone marrow (BM), seed the adult thymus through venules in the cortico-medullary junction (CMJ) [1] . Once in the thymus, these cells differentiate through a series of well-defined developmental stages. CD4
-CD8 -[double-negative (DN)] thymocytes represent the most immature thymocyte subset and consist of four subpopulations: DN1 (CD44 
CD8
ϩ [double-positive (DP)] thymocytes. These proliferating DP thymocytes migrate from the SCR through the cortex and initiate rearrangement of their TCR␣ gene [2] . Productive TCR␣ rearrangement results in expression of TCR␣␤ on the thymocyte surface, which is tested for its capacity to interact with the endogenous MHC. Positively selected DP thymocytes, which have received survival signals through the TCR, differentiate into CD4 ϩ or CD8 ϩ [singlepositive (SP)] thymocytes as they reach the inner cortex, and these cells finally enter the medulla, where they undergo negative selection and terminal differentiation into mature SP cells. Such organized migration of developing thymocytes through distinct thymic niches promotes timely interactions with cortical and medullary thymic epithelial cells (cTEC and mTEC, respectively) and medullary dendritic cells (mDCs) and is believed to play a central role for normal thymocyte development (for reviews, see refs. [1, 3] ).
The chemokine CCL25 is expressed in the normal thymus by cTEC, mTEC, and mDCs [4 -7] . Its receptor CCR9 is expressed on subsets of thymocytes and is tightly regulated during thymocyte development. CCR9 is expressed on a subset of DN thymocytes, and expression is up-regulated dramatically on DP cells following pre-TCR signaling [8 -11] . CCR9 is subsequently down-regulated, as DP thymocytes differentiate into mature SP CD4 ϩ cells, but is maintained in the mouse on SP CD8 ϩ cells [8, 12] . Despite high levels of CCL25/CCR9 in the thymus, adult CCR9 Ϫ/Ϫ mice display normal thymic cellularity and thymocyte composition [13] [14] [15] . Nevertheless, in competitive BM transfer experiments into RAG Ϫ/Ϫ [14] or irradiated wild-type (WT) mice [10, 16] , CCR9 Ϫ/Ϫ cells were shown to have a severe disadvantage prior to or at the DN3 and early thymic progenitor (ETP; c-kit ϩ
CD25
-CD44 ϩ CD4 lo ) stage of development, respectively. This reduced competitiveness of CCR9 Ϫ/Ϫ BM cells in the generation of DN thymocytes has been suggested to reflect defects in thymocyte progenitor generation within the BM [10] and/or seeding of the adult thymus [14, 16] . In addition, CCR9
Ϫ/Ϫ DN2/3 thymocytes are localized throughout the cortex rather than in the SCR, in particular in young (12-to 14-day-old) mice [13] , raising the possibility that CCR9 plays a role in intrathymic T cell development. Nevertheless, under noncompetitive conditions, this relocation of DN2/3 thymocytes appears not to affect subsequent thymocyte development [13] .
To gain further insight into the role of CCR9 in adult thymopoiesis, we compared the competitiveness of CCR9 Ϫ/Ϫ and WT cells in in vivo and in vitro transfer models of thymocyte development. Our results indicate that CCR9 is involved at multiple stages of thymocyte development, including the entry of T cell precursors to the adult thymus, the transition of DN thymocytes into DP cells, and in the generation of mature CD4 SP thymocytes. [15] mice, which had been crossed to C57BL/6 mice for 10 generations, were maintained in the animal facility at the Biomedical Centre, Lund University (Sweden).
MATERIALS AND METHODS

Mice
Antibodies
Anti-FcRII/III (2.4G2) hybridoma was obtained from American Type Culture Collection (Manassas, VA, USA); anti-CD3 (145-2C11), anti-CD4 (RM4-5), anti-CD4 (H129.19), anti-CD5 (53-7.3), anti-CD8␣ (53-6.7), anti-CD8␤ (53-5.8), anti-CD11b (M1/70), anti-CD11c (HL3), anti-CD25 (7D4), anti-CD25 (PC61), anti-CD34 (RAM34), anti-CD44 (IM7), anti-CD45.1 (A20), anti-CD45.2 (104), anti-TCR␣␤ (H57-597), anti-IL-7R␣ (A7R34), anti-TCR␥␦ (GL3), anti-B220 (RA3-6B2), anti-NK1.1 (PK136), anti-Gr-1 (RB6-8C5), antiTer119 (Ter-119), anti-Sca-1 (E13-161.7), anti-c-kit (2B8), rat IgG1 (R3-34), rat IgG2a (R35-95), rat IgG2b (A95-1), and fluorochrome-conjugated streptavidin were purchased from BD Biosciences (Stockholm, Sweden); anti-Sca-1 (D7) from eBiosciences (San Diego, CA, USA); monoclonal anti-CCR9 (7E7) kindly provided by Dr. Oliver Pabst (Hannover Medical School, Germany); tricolor (TC)-conjugated goat anti-rat IgG and PE-Cy5-conjugated sheep antirat from Caltag (Buckingham, UK); anti-rat IgG from Jackson ImmunoResearch Laboratories (West Grove, PA, USA); rat serum and 7-aminoactinomycin D from Sigma-Aldrich (Stockholm, Sweden); and TO-PRO-1 iodide from Molecular Probes (Eugene, OR, USA).
Cell isolation and flow cytometry analysis BM, splenic, and mesenteric lymph node cells and thymocytes were isolated according to standard protocols.
BM cell staining
BM cells were incubated in a cocktail of predetermined optimal concentrations of Lin antibodies to B220, Gr-1, CD11b, CD8, CD5, CD4, and Ter119, followed by a TC-conjugated goat anti-rat antibody. After washing, cells were resuspended in Fc block followed by addition of antibody cocktails for lymphoid-primed multipotent progenitors (LMPP)/Lin -Sca-1 ϩ c-kit ϩ [LSK; Sca-1 FITC, fetal liver tyrosine kinase 3 (Flt3) PE, c-kit allophycocyanin (APC)] or common lymphoid progenitors (CLP; Sca-1 FITC, IL-7R␣ PE, CD3 tandem conjugate, B220 tandem conjugate, c-kit APC).
Thymocyte staining
For ETP analysis, thymocytes were stained with a FITC-conjugated lineage cocktail (anti-CD8␣, CD8␤, TCR␤, TCR␥␦, NK1.1, CD11b, Gr-1, and B220), anti-c-kit APC, and biotinylated anti-CD25, washed and incubated with Pacific blue-conjugated streptavidin. For some experiments, anti-CD44 Alexa-700 and anti-CD45 PE-Cy7 were added as additional markers. For DN subset analysis, thymocytes were incubated with FITC-conjugated lineage cocktail (anti-TCR␥␦, NK1.1, CD11b, Gr-1, and B220), anti-CD45 PE-Cy7, anti-CD4 APC, anti-CD8 PE, anti-CD44 Alexa-700, and biotinylated anti-CD25, washed and incubated with Pacific blue-conjugated streptavidin. For analysis of DN cells from hematopoietic stem cell (HSC) transfers, thymocytes were stained with a lineage cocktail (anti-CD3, -CD4, -CD5, -CD8␣, and -CD11b, B220, Ter119, and Gr-1), directly conjugated anti-CD44, anti-CD25, anti-CD45.1, and anti-CD45.2 antibody.
HSC adoptive transfers
LSK CD34
-(long-term HSC) were isolated and purified (Ͼ98% pure) as described previously [17] [18] [19] [20] OP9-␦-like 1 (OP9-DL1)/LMPP cultures LSKFlt3 hi (highest 25%) LMMP were purified (Ͼ97% pure) as described previously [21, 22] . The OP9-DL1 cell line (kindly provided by Dr. Anna Cumano, Institut Pasteur, Paris, France, and Dr. Juan-Carlos Zuniga-Pflucker, University of Toronto, Toronto, Canada) was maintained as described [23] . Cells were trypsinized and prepared at a density of 2 ϫ 10 4 cells/ml. Single or 10 LMPP were sorted directly onto 48-well plates containing OP9-DL1 cells [supplemented with 25 ng/ml Flt3 ligand (FL)] by a single-cell depositor unit on FACSDiVa (BD Biosciences). In some experiments, 10 LMPP from WT (CD45.1) mice and 10 CCR9 Ϫ/Ϫ (CD45.2) LMPP were sorted directly into the same well. The cocultures were kept in complete OptiMEM medium containing L-glutamine (Invitrogen, Carlsbad, CA, USA), supplemented with FCS (Gibco, Paisley, Scotland) and 25 ng/ml FL for 28 days. Once a week, cytokines were replenished by adding 0.5 ml fresh medium. Clones were analyzed by flow cytometry at 28 days for T cell-committed progenitor analysis (CD45.1, CD45.2, CD4 ϩ CD8 ϩ ), as described previously [21] .
Intrathymic injection
Sublethally irradiated C57BL6.CD45.1 ϩ CD45.2 ϩ mice were injected intrathymically as described previously [24] . Briefly, mice were anesthetized with isofluoran, and a small (1-2 cm) midline incision was made in the skin overlying the lower cervical and upper thoracic region. The upper third of the sternum was then bisected longitudinally to expose the thymus. FACS-sorted WT (Ly5.1 ϩ ) and CCR9 Ϫ/Ϫ DN (Ly5.2 ϩ ) cells were mixed at a 1:1 ratio, and a total of 20,000 cells was injected in a total volume of 10 l into each thymus lobe. Mice were killed 14 days later, and the CCR9 Ϫ/Ϫ :WT donor ratio with the DP thymocyte population was determined by flow cytometry. -DN1 cells were isolated by depletion using anti-CD25-coated Dynabeads (Dynal, Great Neck, NY, USA) and positive selection using anti-CD44-coated Dynabeads and Detachabead, according to the manufacturer's instructions. Purities were typically 98% or greater. In some cases, WT and CCR9 Ϫ/Ϫ DN1 cells were labeled with the fluorescent dyes PKH26 (Sigma-Aldrich) or CFSE (Molecular Probes), respectively [25] .
Fetal thymic organ cultures (FTOC)
Hanging drop recolonization assay Individual 1.35 mM 2-deoxyguanosine (dGuo)-treated FTOC [23] were cultured in Terasaki plates with equal numbers of labeled WT and CCR9 Ϫ/Ϫ DN1 cells (35,000 cells each). The thymus-colonizing ability of WT and CCR9 Ϫ/Ϫ cells was analyzed after overnight culture by disaggregating individual lobes [25] , followed by flow cytometry to detect labeled cells. Long-term developmental potential of introduced cells was analyzed by transferring lobes to normal organ culture conditions, which were analyzed at the indicated timepoints by flow cytometry.
Positive-selection reaggregation thymus organ cultures (RTOC)
Preselection CD4 ϩ 8 ϩ 69 - [25] thymocytes was isolated from adult WT (CD45.1 ϩ ) and CCR9 Ϫ/Ϫ (CD45.2 ϩ ) thymuses by MoFlo cell sorting at a purity of Ͼ99%. Equal numbers of WT and CCR9
Ϫ/Ϫ thymocytes were mixed together with dGuo-treated thymic stromal cell suspensions, obtained from disaggregated 2-deoxyguanosine-treated FTOC (ϳ95% thymic epithelial cells; the remainder thymic fibroblasts), and used to form RTOC, as described [25] . After 5 days, cultures were teased apart, and recovered thymocytes were analyzed for expression of CD4, CD8, and CD45.1.
Thymocyte-epithelial cell conjugate assays
Preselection CD4
ϩ 8 ϩ 69 -thymocytes were prepared from adult WT and CCR9 Ϫ/Ϫ adult thymus [23] , and WT and CCR9 Ϫ/Ϫ cells were fluorescently labeled with DiD (Molecular Probes) and PKH26 (Sigma-Aldrich), according to the manufacturers' instructions. Thymic epithelial cells, obtained by disaggregating dGuo-treated thymic organ cultures as described above, were labeled with CFSE (Molecular Probes). Equal numbers of freshly labeled thymic epithelial cells were mixed with a 1:1 mixture of WT/CCR9 Ϫ/Ϫ thymocytes and centrifuged to form a cell pellet. Analysis of conjugate formation was performed at the indicated times using a BD-LSR (Becton Dickinson, San Jose, CA, USA) flow cytometer, as described [23] .
Statistics
Statistical analysis was performed using paired and unpaired Student's t-test when appropriate.
RESULTS
CCR9
Ϫ/Ϫ HSC are competitively disadvantaged in their ability to generate thymocytes and mature T cells
To determine the role of CCR9 in the generation of thymocyte populations, HSC from CCR9 Ϫ/Ϫ (CD45.2) and WT (CD45.1) mice were transferred into lethally irradiated CD45.1 ϩ CD45.2 ϩ DP recipients, together with CD45.1 ϩ CD45.2 ϩ support BM. Purified HSC was used rather than whole BM to avoid potential differences in the composition of WT and CCR9 Ϫ/Ϫ BM, which may have complicated the interpretation of previous studies [10, 14, 16] . Chimeric mice were killed 6 months after transplantation, and the number of CCR9 Ϫ/Ϫ and WT cells was determined in different organs. The total number of CD4 ϩ , CD8␣
ϩ , and TCR␥␦ ϩ T cells derived from WT HSC was significantly greater than the number derived from CCR9 Ϫ/Ϫ HSC in the spleen of recipient animals, and the number of B cells (B220) and DC (CD11c) derived from WT and CCR9 Ϫ/Ϫ HSC was similar (data not shown). The percentage of DN, DP, and CD8/CD4 SP thymocytes derived from WT HSC was also significantly greater compared with CCR9 Ϫ/Ϫ HSC (Fig. 1A) . Further examination of the DN thymocyte subset demonstrated that WT cells out-competed CCR9 Ϫ/Ϫ cells at the DN1 stage of development (Fig. 1A) . Together, these results confirm previous findings with whole BM-competitive transfers [10, 14, 16] and suggest a role for CCR9 in the earliest stages of T cell development.
Ϫ/Ϫ mice have reduced numbers of ETP Previous studies have shown that adult CCR9 Ϫ/Ϫ mice and 12-to 14-day-old CCR9 Ϫ/Ϫ mice contain normal percentages of DN thymocytes [14, 15] and normal numbers of DN2/3 thymocytes, respectively [13] . Nevertheless, by assessing total DN or DN2/3 populations, differences in DN subset numbers may have been missed. Indeed, in a recent study by Schwarz et al. [16] showed that adult CCR9 Ϫ/Ϫ mice display reduced numbers of ETP and DN2 thymocytes but normal numbers of DN3 cells. We also found that CCR9 Ϫ/Ϫ mice have a significant reduction in thymic ETP and DN2 thymocytes compared with WT animals, while the total number of DN3 and DN4 thymocytes was similar (Fig. 1, B and D, and Supplementary Fig. 1,  A and B) . In addition, the majority of WT ETP expressed CCR9 (Fig. 1C) . Together, these results suggest a central and nonredundant role for CCR9 in the generation of T cell precursors in the BM or in early hematopoietic progenitor seeding of the adult thymus and that compensatory mechanisms exist, which allow the development of normal numbers of DN3-DN4 cells in CCR9 Ϫ/Ϫ mice.
BM T cell progenitor development is normal in CCR9 Ϫ/Ϫ mice
To assess whether the reduced number of ETP in CCR9
Ϫ/Ϫ mice may be a result of reduced T cell progenitor generation in CCR9 Ϫ/Ϫ BM, we examined HSC populations in the BM of CCR9 Ϫ/Ϫ and WT mice ( Fig. 2 and Supplementary Fig. 2 ). The total number of BM LSK and CLP (Lin -IL-7R␣ hi Sca-1 lo ckit lo ) was similar in WT and CCR9 Ϫ/Ϫ mice ( Fig. 2A) . In addition, LSK cells that express high levels of Flt3, termed LMPP and displaying potent lymphoid progenitor cell potential [21] , were found in the same numbers in WT and CCR9 Ϫ/Ϫ BM ( Fig. 2A) . As LMPP represent a likely source of T cell progenitors in the BM, the potential of CCR9 Ϫ/Ϫ and WT LMPP to generate T cells was assessed in OP9-DL1 stromal cell cultures. LMPP (single or 10 cells) from CCR9 Ϫ/Ϫ (Ly5.2) and WT (Ly5.1) mice were sorted onto confluent OP9-DL1 stromal cells, and their ability to generate CD4 ϩ CD8 ϩ DP T cells was assessed 28 days later by flow cytometry. The cloning efficiency and the proportion of clones generating DP T cells in wells seeded with single WT and CCR9 Ϫ/Ϫ LMPP were similar (Fig. 2B ). In addition, seeding of 10 CCR9 Ϫ/Ϫ or WT LMMP/ well resulted in a similar percentage of wells containing DP T cells (Fig. 2B) . Moreover, CCR9
Ϫ/Ϫ LMPP appeared not to be disadvantaged compared with their WT counterparts in generating T cell clones in competitive OP9-DL1 cultures (Fig. 2C) . Together, these results suggest that the reduction in ETP in adult CCR9
Ϫ/Ϫ mice and disadvantage of CCR9 Ϫ/Ϫ HSC in generating early DN thymocytes may be a result of reduced T cell progenitor seeding of the adult thymus rather than a reduced T cell progenitor potential of CCR9 Ϫ/Ϫ BM.
CCR9
Ϫ/Ϫ DN1 thymocytes are competitively disadvantaged at generating DP cells DN2/3 thymocytes are normally located in the SCR; however, in CCR9 Ϫ/Ϫ mice, they are distributed evenly throughout the thymic cortex [13] , indicating a role for CCR9 in the positioning of developing DN thymocytes within the thymus. Nevertheless, this altered localization under noncompetitive conditions does not appear to affect subsequent thymocyte development [13] . To examine in more detail a potential role for CCR9 in the transition of DN to DP thymocytes, CCR9
Ϫ/Ϫ and WT DN1 thymocyte development was analyzed in FTOC. Under noncompetitive culture conditions, DN1 cells from CCR9 Ϫ/Ϫ mice generated similar numbers of DP thymocytes as their WT counterparts (Fig. 3, A and B) . It is notable that although the number of CD8 SP thymocytes arising from CCR9 Ϫ/Ϫ and WT DN1 cells appeared the same, the total number of CD4 SP thymocytes was reduced slightly but significantly (Fig. 3, A and  B) . To determine whether CCR9 Ϫ/Ϫ DN1 cells are competitively disadvantaged in their ability to generate DP and SP thymocytes, CCR9
Ϫ/Ϫ and WT DN1 competitive FTOC cultures were performed. CCR9
Ϫ/Ϫ and WT DN1 cells were equally effective in entering fetal thymic lobes (Fig. 4, A and  B) . Nevertheless, CCR9
Ϫ/Ϫ DN1 cells were disadvantaged in Fig. 1 their ability to generate DP and as a consequence, CD4 and CD8 SP thymocytes, compared with WT cells (Fig. 4, C and D) . To confirm these findings in vivo, DN thymocytes from CCR9 Ϫ/Ϫ and WT mice were mixed at a 1:1 ratio and injected intrathymically into sublethally irradiated recipients, and the ratio of CCR9 Ϫ/Ϫ :WT cells within the developing DP population was assessed 14 days later. Within the DP thymocyte compartment, CCR9
Ϫ/Ϫ cells were found at reduced numbers compared with WT cells in nine of 11 animals (Fig. 4, E and  F) , thus confirming the data obtained with FTOC. Together, these results indicate a role for CCR9 in promoting the transition of DN thymocytes to DP cells.
Ϫ/Ϫ preselection DP thymocytes are disadvantaged in generating CD4 SP thymocytes in competitive RTOC CD4 SP and CD8 SP thymocytes are found in normal frequencies and numbers in CCR9 Ϫ/Ϫ mice [14, 15] and display normal medullary distribution (Supplementary Fig. 3 ). Although the reduction of CD4 SP cells in FTOC receiving CCR9 Ϫ/Ϫ DN1 cells alone (Fig. 3A) may be a result of reduced numbers of immature CD4 ϩ CD3 -or CD4 ϩ TCR␥␦ cells, an alternative explanation for this finding is that CCR9 is involved 
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-thymocytes were isolated from CCR9 Ϫ/Ϫ and WT mice, mixed at a 1:1 ratio, and placed in RTOC. In these experiments, the total number of CCR9 Ϫ/Ϫ DP thymocytes was slightly but significantly higher than that of WT DP cells (Fig. 5, A and B) , indicating that CCR9 does not play an important role in DP thymocyte survival in these cultures. Nevertheless, although CCR9 Ϫ/Ϫ CD4 ϩ 8 ϩ 69 -thymocytes were slightly more efficient at generating CD8 SP thymocytes compared with WT cells, they were significantly less efficient at generating CD4 SP thymocytes (Fig. 5, A and B) . CCR9 Ϫ/Ϫ CD4 SP and CD8 SP thymocytes expressed high levels of CD3 similar to WT cells, confirming that CCR9 Ϫ/Ϫ DP thymocytes were disadvantaged in generating mature CD4 SP thymocytes (Fig. 5C) . The duration of antigen receptor signaling plays a central role in the development of CD4 and CD8 SP thymocytes from DP precursors [26, 27] , and prolonged signal duration is required for the development of CD4 SP cells [27] . We therefore hypothesized that the selective deficiency in the ability of CCR9 Ϫ/Ϫ DP thymocytes to generate CD4 SP cells may be a result of the reduced ability of these cells to form stable interactions with thymic epithelial cells. To address this possibility, we analyzed initial stages of positive selection using thymocyte-epithelial cell conjugate assays, in which cell-cell contact is dependent on TCR-MHC interactions. CCR9
Ϫ/Ϫ and WT preselection DP thymocytes were labeled with the fluorescent dyes DiD and PKH26, respectively, and mixed at a 1:1 ratio, and their ability to interact with CFSE-labeled thymic epithelial cells was assessed in conjugate assays [25] . Results from this analysis demonstrate that CCR9 Ϫ/Ϫ CD4 ϩ 8 ϩ thymocytes are disadvantaged significantly compared with their WT counterparts in generating stable conjugates with thymic epithelial cells (Fig.  5, D and E) . These results suggest that CCR9-mediated interactions with thymic epithelial cells are involved during initial stages of thymocyte positive selection.
DISCUSSION
Despite high expression of CCL25 and CCR9 by thymic stromal cells and developing thymocytes, respectively, the role of this chemokine/chemokine receptor pair in adult hematopoiesis remains unclear. Adult CCR9 Ϫ/Ϫ mice have normal numbers of DN, DP, and SP thymocytes [13] [14] [15] , indicating that CCR9 is not involved in adult thymocyte development or that compensatory mechanisms are in place allowing normal thymopoiesis in these animals. Here, we addressed this question using competitive CCR9 Ϫ/Ϫ /WT cell transfers in in vitro and in vivo models of progenitor and thymocyte development. Our results suggest a role for CCR9 in three distinct stages of adult thymopoiesis-first, in hematopoietic progenitor seeding of the thymus; second, in the intrathymic generation of DP thymocytes; and finally, in the development of CD4 SP cells from DP thymocytes. CCR9 Ϫ/Ϫ BM cells are disadvantaged in their ability to generate DN3 and ETP cells after competitive whole BM transfer into RAG Ϫ/Ϫ and WT mice, respectively [10, 14, 16] , and these results were confirmed in the present study using competitive, purified HSC transfers. Furthermore, consistent with a recent publication [16] , thymic ETP and DN2 cells but not DN3/4 populations were reduced significantly in adult CCR9 Ϫ/Ϫ mice, indicating an important role for CCR9, even under noncompetitive conditions in the development of T cell progenitors in the BM and/or in hematopoietic cell seeding of the adult thymus. The observation that subsets of BM, MPP, and CLP express CCR9 [16] and that enhanced green fluorescent protein (EGFP) ϩ cells are found among BM, LSK, and CLP in CCR9-EGFP reporter mice [28] indicates that CCR9 may function in progenitor development within the BM. Indeed, the absence of CCR9 on ETP has been used to argue for a role for CCR9 in the generation of T cell precursors in the BM and not in thymic seeding [10] . Nevertheless, in contrast to the findings of Wurbel et al. [10] , but consistent with two recent studies [16, 29] , we found that thymic ETP express CCR9. We demonstrate further that CCR9 Ϫ/Ϫ BM contains normal numbers of HSC, CLP, LSK, and LMPP, and importantly that single CCR9 Ϫ/Ϫ LMPP are equally capable of generating DP T cells on OP9-DL1 stromal cells as WT LMPP. Collectively, these results argue against a role for CCR9 in T cell progenitor development in the BM.
A role for CCR9 in T cell progenitor seeding of the adult thymus is at odds with the observation that adoptively transferred Lin -BM cells from CCR7/CCR9 double-KO mice are equally efficient at entering the adult thymus as their WT counterparts [30] . However, the use of total Lin -cells may have masked a role for CCR9 in thymic seeding of a minor but relevant population of thymocyte progenitors in this study. Indeed, i.v.-injected CCR9
Ϫ/Ϫ BM cells were shown recently to populate the BM LSK population of mice with a similar efficiency as WT BM cells but were less efficient at generating thymic ETP. In contrast, intrathymically injected WT and CCR9 Ϫ/Ϫ BM cells were equally efficient at generating ETP [16] . Although the identity of the T cell progenitors that seed the adult thymus under physiological conditions, is currently unclear [31] , i.v.-injected CLP-2 cells, which have T cell precursor potential [32] , require CCR9 for efficient entry into the thymus [33] . CLP-2 are unlikely to represent a thymic seeding population as they are not found in blood, however, Krueger and von Boehmer [29] recently detected a T lineagecommitted progenitor in blood, which they termed circulating T cell progenitors, and these cells expressed high levels of CCR9. Together with our current findings that CCR9 Ϫ/Ϫ BM has normal T lymphocyte potential, these results collectively suggest a role of CCR9 in hematopoietic progenitor seeding of the adult thymus.
CCR9 is expressed at low-to-intermediate levels on DN2 and DN3 thymocytes, respectively [9, 10] , and at high levels on DN4/DP thymocytes as a result of pre-TCR signal-induced CCR9 transcription at the DN3 stage [8 -11, 34] , indicating a potential role for CCR9 in the development of DP thymocytes from their DN precursors. Nevertheless, adult CCR9 Ϫ/Ϫ mice have normal numbers of DP thymocytes [13] [14] [15] . Consistent with these findings, we observed that CCR9 Ϫ/Ϫ DN1 cells were as efficient as their WT counterparts at generating DP thymocytes in FTOC cultures under noncompetitive conditions. However, under competitive conditions, CCR9 Ϫ/Ϫ DN1 thymocytes displayed a marked reduction in their ability to generate DP thymocytes. Furthermore, DN thymocytes from CCR9 Ϫ/Ϫ mice were competitively disadvantaged compared with WT cells in their ability to generate DP thymocytes following intrathymic injection. In competitive OP9-DL 1 cultures, CCR9 Ϫ/Ϫ and WT LMPP were equally efficient in generating DP thymocytes; however, OP9-DL1 cells do not appear to express CCL25 (unpublished observation). Collectively, these findings suggest that the advantage of WT over CCR9 Ϫ/Ϫ cells is a result of microenvironmental factors, presumably as a result of competition for epithelial-derived CCL25. CCR9
Ϫ/Ϫ DN2/3 thymocytes display aberrant localization throughout the thymic cortex, in particular, in younger (12-to 14-day-old) mice [13] . Thus, aberrant localization of CCR9 Ϫ/Ϫ DN2/3 cells may result in developmental disadvantage compared with WT cells under competitive conditions. Of note, Uehara et al. [34] recently generated two transgenic mouse lines expressing CCR9 under control of the human CD2 promoter, and one of these lines showed a partial developmental block at the DN3 stage of development, as a result, at least in part, of a proliferative defect during the DN3-4 transition. Thus, the regulated expression of CCR9 also appears to be required for efficient development of DN cells into DP thymocytes. Although the compensatory mechanisms, which allow normal DP thymocyte development in CCR9 Ϫ/Ϫ mice or in noncompetitive FTOC, remain to be determined, two potential candidate molecules are the chemokine receptors CCR7 (expressed on DN1-2 and a subpopulation of DN4 thymocytes) and CXCR4 (expressed on virtually all DN2/3/4/DP thymocytes) [9, 35] . CCR7 and CXCR4 have demonstrated roles in adult intrathymic DN thymocyte development [9, 35] , and further studies using combinatorial KO should help determine any overlapping function for these receptors in the development of DP thymocytes.
CCR9 is expressed at high levels on DP thymocytes, on immature (CD69 ϩ CD62L -) but not mature (CD69 -CD62L ϩ ) SP CD4 thymocytes, and on mature and immature SP CD8 thymocytes [8, 9, 36] . CCR9 Ϫ/Ϫ mice have normal numbers of DP and SP thymocytes [14, 15] , indicating that CCR9 is not involved in the DP-to-SP transition or that there are compensatory mechanisms in place to ensure normal SP development. Here, we demonstrate that CCR9 Ϫ/Ϫ DN1 cells generate similar numbers of DP and CD8 SP thymocytes as WT DN1 cells in noncompetitive FTOC. Furthermore, in competitive RTOC, CCR9 Ϫ/Ϫ DP and SP CD8 cells were increased compared with WT, although the differences in CD8 SP numbers did not reach significance. Thus, CCR9 does not appear to play a role in the maintenance of DP thymocytes or in the development of CD8 SP cells in these cultures. In contrast, in noncompetitive FTOC cultures, we found that CCR9 Ϫ/Ϫ DN1 cells showed a slight but significant disadvantage in generating SP CD4 cells. More strikingly, in competitive RTOC CCR9 Ϫ/Ϫ preselection DP thymocytes were selectively disadvantaged in their ability to generate CD4 SP cells. This finding suggested to us that under competitive conditions, CCR9
Ϫ/Ϫ DP thymocytes in RTOC received efficient signals for CD8 SP but not CD4 SP thymocyte development. Yasutomo et al. [27] , using a modified, two-stage reaggregate culture system, demonstrated recently that the duration of antigen receptor signaling determines CD4 versus CD8 T cell lineage fate. Thus, short TCR signaling in DP cells results in the preferential generation of CD8 SP thymocytes, and extended signaling results in the preferential generation of CD4 SP thymocytes. In competitive aggregation studies, we found that CCR9 Ϫ/Ϫ preselection thymocytes are compromised in their ability to form conjugates with thymic epithelial cells. Together, these results suggest an important role for CCR9 in regulating DP thymocyte interactions with thymic epithelial cells and provide a likely molecular explanation for the selective reduction of CCR9 Ϫ/Ϫ CD4 SP cells in competitive RTOC. We hypothesize that compensatory adhesive interactions between DP thymocytes and thymic epithelia, potentially mediated by other chemokines, allow CD4 SP development to proceed normally in adult CCR9
Ϫ/Ϫ mice. In conclusion, using competitive transfer models, the current study provides new insights into the role of CCR9 at multiple stages of adult thymopoiesis. The future challenge will be to unravel the complex compensatory signaling networks and overlapping functional events that allow thymocyte development to proceed relatively unperturbed in animals deficient in this receptor.
